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DRUG-INDUCED ECG CHANGES: BEYOND THE QT INTERVAL 
 
Electrocardiographic QT interval prolongation is one of the most common 
causes of delays and non-approvals in drug development due to the qualitative 
relationship between this interval and Torsade de Pointes (TdP) arrhythmia. 
However, not all drugs that prolong the QT interval to the same extent carry the 
same risk for TdP. Other ECG indications, such as abnormal T-wave morphol-
ogy, may play a role in differentiating between safe and unsafe drugs. 
We used moxifloxacin (non-Torsadogenic) and d,l-sotalol (Torsadogenic) to 
investigate whether concurrent changes for QT and T-wave morphology could 
be used to describe the discrepancy in proarrhythmic risk between the two 
drugs. T-wave morphology changes (ΔMCS) were quantified using a composite 
measure of flatness, asymmetry and notches. QT interval changes (ΔQTcF) 
were measured using standard ECG software. 
Our results provide evidence that these drugs have significantly different 
morphology-duration profiles at similar QT prolongations, figure 1. These find-
ings could have important implications for cardiac safety evaluation of new 
medications because they challenge the current practice of using a fixed QT 
threshold as the limit for regulatory concern. 
 
 
 
Fig. 1: The change in T-wave morphology (ΔMCS) for a given QT interval 
prolongation (ΔQTcF) appears to be drug and dose specific. 
 
 
 
